GSK2292767
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 522376

CAS#: 1254036-66-2 (free base)

Description: GSK2292767 is a potent and selective PI3Kδ inhibitor. GSK2292767 is is currently in clinical trials for the treatment of respiratory diseases such as asthma and COPD. GSK2292767 is highly selective for PI3Kδ over the closely related isoforms and are active in a disease relevant brown Norway rat acute OVA model of Th2-driven lung inflammation. PI3Kδ is highly enriched in leukocytes, making it an attractive target for the treatment of inflammatory conditions, such as asthma,6 chronic obstructive pulmonary disease (COPD), and autoimmune diseases.

Chemical Structure

img
GSK2292767
CAS# 1254036-66-2 (free base)
Handing Instruction

Theoretical Analysis

MedKoo Cat#: 522376
Name: GSK2292767
CAS#: 1254036-66-2 (free base)
Chemical Formula: C24H28N6O5S
Exact Mass: 512.18419
Molecular Weight: 512.58
Elemental Analysis: C, 56.24; H, 5.51; N, 16.40; O, 15.61; S, 6.25

Size Price Shipping out time Quantity
5mg USD 315 2 Weeks
10mg USD 550 2 Weeks
25mg USD 1100 2 Weeks
Inquire bulk and customized quantity
Pricing updated 2021-02-27. Prices are subject to change without notice.

GSK2292767, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.

Synonym: GSK2292767; GSK-2292767; GSK 2292767.

IUPAC/Chemical Name: N-(5-(4-(5-(((2R,6S)-2,6-dimethylmorpholino)methyl)oxazol-2-yl)-1H-indazol-6-yl)-2-methoxypyridin-3-yl)methanesulfonamide

InChi Key: NLUPPCTVKHDVIQ-GASCZTMLSA-N

InChi Code: InChI=1S/C24H28N6O5S/c1-14-11-30(12-15(2)34-14)13-18-9-26-23(35-18)19-5-16(6-21-20(19)10-27-28-21)17-7-22(29-36(4,31)32)24(33-3)25-8-17/h5-10,14-15,29H,11-13H2,1-4H3,(H,27,28)/t14-,15+

SMILES Code: CS(=O)(NC1=CC(C2=CC3=C(C(C4=NC=C(CN5C[C@@H](C)O[C@@H](C)C5)O4)=C2)C=NN3)=CN=C1OC)=O

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO, not in water

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:
2934.99.9001

Certificate of Analysis:
View CoA: current batch, Lot#C20M01C20

Safety Data Sheet (SDS):
View Safety Data Sheet (SDS)

Handling Instructions:
View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 512.58 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Down KD, Amour A, Baldwin IR, Cooper AW, Deakin AM, Felton LM, Guntrip SB,
Hardy C, Harrison ZA, Jones KL, Jones P, Keeling SE, Le J, Livia S, Lucas F,
Lunniss CJ, Parr NJ, Robinson E, Rowland P, Smith S, Thomas DA, Vitulli G, Washio
Y, Hamblin N. Optimization of Novel Indazoles as Highly Potent and Selective
Inhibitors of Phosphoinostide-3-Kinase Delta for the Treatment of Respiratory
Disease. J Med Chem. 2015 Aug 24. [Epub ahead of print] PubMed PMID: 26301626.

img

GSK2292767

5mg / USD 315


Additional Information

GSK2292767 is an analogue of GSK2269557